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A B S T R A C T   
The problematic increase in multidrug-resistant bacteria translates into the urgent need to discover novel and 
effective antimicrobial substances. Herein, mushrooms could be a promising alternative of natural source of new 
antimicrobials. The present work aimed to compare the phytochemical composition and antimicrobial activity of 
methanol and aqueous crude extracts of Lentinula edodes var. Koshin and Donko. Disk diffusion method was used 
to screen the antimicrobial activity and to assess the synergistic effect of the mushroom extracts. Microdilution 
method was used to determine the minimum inhibitory concentration (MIC) and the minimum bactericidal 
concentration (MBC). Phytochemical characterization of mushrooms extracts was achieved by analysis of total 
phenols, ortho-diphenols content and its antioxidant activity. The results noticed a positive relation between 
phenolic compounds content, antioxidant activity, and antimicrobial capacity of the mushroom’s extracts. The 
L. edodes var. Koshin aqueous extracts, which contained the highest amount of total phenolic compounds, 
exhibited the highest scavenging capacity of ABTS which, in turns, exhibited the highest antimicrobial efficacy in 
inhibiting the growth of methicillin-resistant Staphylococcus aureus. Moreover, the combination between mush-
rooms extracts and commercial antibiotics showed favorable synergistic effects against tested bacteria. These 
results suggest that L. edodes var. Koshin may represent an important and valuable therapeutic source of com-
pounds to be used against multidrug-resistant bacteria.   
1. Introduction 
Nowadays, the world is witnessing a dramatic increase related to 
multidrug-resistant bacteria. The indiscriminate use of antibiotics, 
among other factors, has been contributed to the development of resis-
tant organisms, leading to easily curable diseases becoming a serious 
problem (McAdam et al., 2012). 
In 2014, the World Health Organization advised that antibiotic 
resistance reveals serious worldwide threat to Public Health, high-
lighting the risks associated to the absence of alternative therapies 
against multidrug-resistant microorganisms (WHO, 2014). In 2015 the 
European Centre for Disease Prevention and Control estimated 671,689 
infections in the EU and European Economic Area caused by 
multidrug-resistant bacteria, resulting in 33,110 deaths, most of them 
acquired in healthcare settings (Weist and Högberg, 2016). In 2017, 
WHO published its first list of antibiotic-resistant "priority pathogens" – 
a catalogue of 12 families of bacteria which pose the greatest threat to 
human health. This list was drawn up in a bid to guide and promote 
research and development of new antibiotics. It is divided into three 
categories according to the urgency of need for new antibiotics: critical, 
high and medium priority (WHO, 2017). 
One of the most troubling problems with antibiotic resistance is 
healthcare associated infections (HCAIs). HCAIs are associated with 
prolonged hospital stay, which in turns leads, to an increasedcosts, 
morbidity and mortality (WHO, 2011). Hence, notwithstanding the 
impossibility to prevent bacteria evolution, it is important to discover 
novel, natural, and effective antimicrobial substances against patho-
genic microorganisms resistant to conventional treatments. Naturally 
produced antimicrobials have gained an increase of popularity and, 
among them, mushrooms could be a promising alternative as source of 
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new antimicrobials (Gyawali and Ibrahim, 2014; Zdenka et al., 2016). In 
fact, mushroom species release several bioactive compounds, such as 
terpenoids, flavonoids, tannins, alkaloids, and polysaccharides which 
could be used as novel antibiotics. Herein, Lentinula edodes (shiitake 
mushrooms) has been attracted particular attention concerning its 
antimicrobial activity (Bender et al., 2001). Therefore, in the present 
work, the in vitro antimicrobial activity of Lentinula edodes var. Donko 
and Koshin aqueous and methanolic extracts was screened against 
several clinical isolates of carbapenem-resistant Klebsiella pneumoniae 
and methicillin-resistant Staphylococcus aureus that belong to the WHO 
critical and high priority agent groups. Those clinical isolates are from 
CHTMAD – Hospital Center of Trás-os-Montes and Alto Douro, Portugal. 
The comparison between the two mushroom varieties was taken into 
account since there are substantial differences in morphology and 
growing conditions which may interfere on the content of bioactive 
compounds and biological activities. In fact, the var. Donko grows 
slowly at low temperatures, and present a thick cap, short stalk and dark 
brown color (Figure 1A). On the other hand, var. Koshin develops 
rapidly at mild temperatures and it has a thin cap and a pale coloration 
(Figure 1B) (Miles and Chang, 2004). 
Considering the results of the antimicrobial activity, the most 
promising species extracts were combined with commercial antibiotics 
against different clinical isolates, including multidrug-resistant micro-
organisms. Moreover, for the first time, the two varieties of L. edodes 
were compared regarding the antimicrobial activity and phytochemical 
composition. 
2. Material and Methods 
2.1. Chemicals and drugs 
Methanol was of analytical grade purity from Lab-Scan (Lisbon, 
Portugal). The culture media Brain Heart Infusion agar (BHIA), Mueller 
Hinton broth (MHB), Mueller Hinton agar (MHA) and all antibiotics 
were obtained from Oxoid (Humpshire, UK). The saline solution was 
prepared with NaCl from Merck (Darmstadt, Germany). The dye resa-
zurin was purchased from Sigma–Aldrich (St Louis, MO, USA) to be used 
as microbial growth indicator. 
2.2. Mushrooms material 
Lentinula edodes var. Donko and Koshin mushrooms, produced in 
Floresta Viva company (Amarante, Portugal), were stored at − 20◦C, 
freeze-dried (Dura Dry TM μP, − 41◦C and 500 mTorr) and grounded to a 
fine powder. 
2.3. Lentinula edodes extracts 
Mushrooms extracts were obtained by two different extraction 
methods: (1) Exhaustive aqueous extracts: 5g of dried mushrooms ma-
terial was added to 150 mL of distilled water. The mixture was agitated 
at room temperature (orbital shaker, one hour, 150 rpm), then centri-
fuged. The supernatant was filtered (Whatman no. 4 filter paper), and 
again 100 mL of distilled water was added to the pellet. The whole 
procedure was repeated to a total of 4 times. The total extracted was 
stored at − 20◦C before lyophilization to obtain the final extract; (2) 
Exhaustive methanolic extracts: 5g of dried mushrooms material was 
added to 150 mL of a 80% methanol solution (methanol/distilled water 
v/v). The mixture was agitated at room temperature (orbital shaker, one 
hour, 150 rpm), then centrifuged. The supernatant was filtered and 
again 100 mL of the previous solution was added to the pellet. The whole 
procedure was repeated to a total of 4 times. The total extracted volume 
was concentrated in a vacuum rotary evaporator at 38◦C to remove 
methanol and stored at − 20◦C before lyophilization to obtain the final 
extract. 
2.4. Microorganisms and culture media 
The microorganisms used were clinical isolates from patients hos-
pitalized in various departments of Hospital Centre of Trás-os-Montes 
and Alto Douro (CHTMAD) - these are located in the cities of Lamego, 
Peso da Régua, Chaves, and Vila Real, Portuguese north province of 
Trás-os-Montes and Alto Douro. Ethical approval for this study was 
granted by the Ethics Committee of Hospital Vila Real (CHTMAD), ac-
cording to a research collaboration protocol established in 2004. These 
strains belong to MJH and MJMC collections and are stored at − 70◦C in 
aliquots of BHI (Brain Heart Infusion) medium with 15% (v/v) glycerol, 
in the Microbiology Laboratory of the Veterinarian Science Department 
at UTAD. Six Gram-negative bacteria, Klebsiella pneumonia isolated from 
biological fluids (MJH 513, MJH 569, MJH 579, MJH 599, MJH 602, 
MJH 640, MJH 662), and thirteen Gram-positive bacteria, methicillin- 
sensitive Staphylococcus aureus (MSSA) (MJMC 018, MJMC 026, 
MJMC 109, MJMC 110, MJMC 511) and methicillin-resistant S. aureus 
(MRSA) (MJMC 025, MJMC 027, MJMC 102, MJMC 111, MJMC 507, 
MJMC 534 B, MJMC 539, MJMC 545, MJMC 552), isolated from wound 
exudates, were used to screen the antimicrobial activity of the mush-
room extracts. All strains were identified by morphological and 
biochemical tests (morphological identification of colonies, Gram 
staining, conventional biochemical identification methods and Micro-
Scan WalkAway identification panels), followed by Kirby-Bauer anti-
biotic sensitivity assays, using different antibiotics (10 μg). 
Escherichia coli (CETC 434) and Staphylococcus aureus (CETC 976) 
strains were obtained from Spanish Type Culture Collection (CETC). Ethics 
approval for this study was granted by the Ethics Committee of Hospital 
Figure 1. Lentinula edodes Donko (A) and Koshin (B) varieties  
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Vila Real. 
2.5. Antimicrobial activity 
Briefly, bacterial suspension with the turbidity adjusted to 0.5 
McFarland standard units, were spread with a sterile cotton swab onto 
Petri dishes (90mm of diameter) containing 4 mm of Mueller-Hinton 
agar. Six-millimeter diameter sterile paper discs were dispensed on the 
seeded agar plates and imprinted with 12 μL of 1000 µg.mL− 1 extracts 
solution (in Dimethyl Sulfoxide (DMSO) 10%). Incubation for 24 h at 
37◦C, followed by diameter measurement (mm) of the clear inhibitory 
zones around the discs imprinted with the extracts. In all experiments, a 
negative control (12 μL DMSO) and a positive control [standard com-
mercial antibiotic gentamicin (10 µg)] were included. 
The antimicrobial activity was classified according to the following 
scheme: noneffective (-): inhibition halo = 0; moderate efficacy (+): 0 <
inhibition halo < antibiotic inhibition halo; good efficacy (++): anti-
biotic inhibition halo < inhibition halo < 2x inhibition halo; strong ef-
ficacy (+++): inhibition halo > 2x antibiotic inhibition halo (Aires et al., 
2009). 
Minimum inhibitory concentration (MIC, lowest concentration of 
mushroom extract able to inhibit bacterial growth) was evaluated by a 
resazurin microdilution assay (Sarker et al., 2007). Bacteria tested were 
picked from overnight cultures in BHIA. A small portion of bacteria was 
transferred into a bottle with 50 mL of MHB, capped and placed in an 
incubator overnight at 37◦C. After 16 h of incubation, bacterial sus-
pension was adjusted to an optical density of 0.5 measured at OD500 
nm. The resazurin solution (3.4 mg.mL− 1) was prepared in sterile 
distilled water. A 96-wells sterilized microplate was used and a volume 
of 100 μL of MHB was used in each well, together with 200 μL of extract 
solution, or positive control. From the first well (belonging to the first 
horizontal line) 100 μL was taken and added to the next well and then 
this step was repeated to each of the following wells in the vertical line, 
allowing a serial fold dilution of decreasing concentration (range of 
1000 µg.mL− 1 to 7.81 µg.mL− 1). In addition, 20 μL of bacterial sus-
pension and 20 μL of resazurin solution was added to each well. 
Microplates were incubated at 37◦C for 18–24 h. All tests were per-
formed in triplicate and MIC was then assessed visually by the color 
change of resazurin in each well (blue to pink in the presence of bacteria 
growth). For the determination of minimum bactericidal concentration 
(MBC, the lowest concentration of mushroom extract at which bacterial 
growth by at least 99.0%), the content from each well without changes 
in color was plated on Mueller-Hinton Agar and incubated at 37 ◦C for 
24 h. The lowest concentration that yielded no growth after this sub-
culturing was taken as the MBC. 
2.5.1. Synergistic effect 
The screening of synergistic effects was performed by the disk 
diffusion method in solid medium. Taking into account the antimicro-
bial results, the synergistic effect was only evaluated for L. edodes var. 
Koshin. Two discs were dispensed into the plates by antibiotic and one of 
them was impregnated with 12 µL of the mushroom extract solution. 
Seven antibiotics were used: gentamicin (CN), amoxicillin/clavulanic 
acid (AMC), ciprofloxacin (CIP), vancomycin (VA), imipenem (IPM), 
ertapenem (ETP) and meropenem (MEM). 
2.6. Determination of total phenolic compounds 
The total phenolic compounds in the extracts were determined by the 
Folin–Ciocalteu method as previous described (Gouvinhas et al., 2017), 
with some modification. Briefly, 10 µL of mushrooms extract at a con-
centration of 1 mg.mL− 1 or gallic acid standards (0.01 to 1.0 mg.mL− 1 in 
methanol) were mixed with 185 µL of distilled water in a 96-well plate 
followed by the addition of 25 µL of Folin-Ciocalteu reagent. After an 
incubation period of 5 min, sodium carbonate (75 µL of 7% Na2CO3) was 
added and further incubated for 2 h in the dark and at room 
temperature. The absorbance was then measured at 725 nm against a 
blank on a Biotek Powerwave XS2 plate reader (BioTek Instruments, Inc. 
USA) at 25 ◦C. The phenolic content was expressed as mg gallic acid 
equivalents per gram of extract (mg GAE/g dry weight). 
2.7. Ortho-diphenols content 
For the analysis of the ortho-diphenols content, a colorimetric 
method, based on a complex reaction with sodium molybdate dehy-
drate, was applied (Ferreira et al., 2020). Briefly, extract aliquots (60 µL 
at a concentration of 1 mg.mL− 1) or gallic acid standards (0.01 to 1.0 
mg.mL− 1 in methanol) were reacted for 25 min with 200 µL of a sodium 
molybdate dihydrate solution (5% prepared in ethanol/water, 1:1 v/v). 
The absorbance of the samples and standards was measured at 370 nm 
against to blank (ethanol/water 1:1, v/v) on a plate reader at 25 ◦C. The 
results were expressed as mg of gallic acid equivalents per gram of 
extract (mg GAE/g dry weight). 
2.8. Radical Scavenging Activity on ABTS radical 
The radical scavenging activity of both mushroom extracts on ABTS 
(2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) radical cation 
was measured using a spectrophotometric methodology, according to a 
previously described procedure (Ferreira et al., 2020). Briefly, an ABTS 
radical cation stock solution (7.4 mM) was prepared by reacting equal 
amounts of ABTS and potassium persulfate (2.6 mM) and allowing to 
stand 16 h in the dark and at room temperature. The radical solution was 
then diluted with methanol to an absorbance of 0.70 (±0.02) at 734 nm 
at 25 ◦C. The samples (10 µL ranging from 0.0625 to 1 mg.mL− 1) were 
mixed with 190 µL of the radical solution and after 6 min incubation the 
absorbance was measured. The results were expressed as Trolox equiv-
alent antioxidant capacity (mM Trolox / g dry weight). 
2.9. Statistical Analysis 
For the evaluation of antimicrobial activity, all assays were carried 
out in duplicate and the results are expressed as mean ± standard de-
viation. Regarding the chemical characterization of the extracts, all as-
says were performed in triplicate. Data are expressed as mean ±
standard deviation and were statistically analyzed by one-way analysis 
of variance (one-way ANOVA), followed by Holm-Sidak’s multiple 
comparison test. Statistical analyzes were performed using GraphPad 
Prim for Windows (Version 7) and differences were considered signifi-
cant when p <0.05 (95% significance). 
3. Results 
3.1. Antimicrobial susceptibility of clinical isolates 
Concerning the assessment of antibiotic susceptibility, the results 
revealed that some of the clinical isolates used are multidrug-resistant 
bacteria (Tables 1 and 2) being a problem due to the insufficient alter-
natives of effective antibiotics. As seen in Table 1, in Gram-positive 
clinical bacteria isolated from wound infections, the methicillin, cipro-
floxacin and levofloxacin had the highest antibiotics resistance. The 
clinical isolates MJMC 534 B, MJMC 539 and MJMC 552 are resistant to 
7, 8 and 9 antibiotics, respectively, being the most multidrug-resistant 
bacteria. Gentamicin and vancomycin are the most effective antibi-
otics, as thirteen of the fourteen isolates are sensitive to those 
antibiotics. 
Concerning to Gram-negative clinical bacteria isolated from different 
types of biological samples (Table 2), all microorganisms were resistant 
to amoxicillin / clavulanic acid and ertapenem, a carbapenem used as a 
last resort in the treatment of Extended-Spectrum β-lactamase (ESBL) 
-producing bacterial infections. The clinical isolates MJH 569 and MJH 
599 have the highest number of antibiotic resistances, being evident the 
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low sensitivity to the β-lactam antibiotic group. 
3.2. Antimicrobial activity evaluation of extracts 
The L. edodes extracts were tested at concentration of 500 µg.mL− 1 
and it was observed that by increasing the concentration to 1000 µg. 
mL− 1, the size of the inhibition halos also increased. Therefore, only the 
results obtained with the concentration of 1000 µg.mL− 1 are presented 
in this work. Data obtained on screening of antimicrobial activity of the 
two varieties of L. edodes extracts, against Gram-positive and Gram- 
negative bacteria, are shown in Table 3. Concerning to aqueous ex-
tracts, the bacterial inhibition halos varied between 7 – 11 mm and 
between 7 – 16 mm for var. Donko and var. Koshin, respectively 
(Figure 2 and Table 3). Methanolic extracts of both varieties were not 
effective against either isolate tested. Also, Gram-negative isolates were 
resistant to all extracts tested. 
Therefore, and according to the classification scheme proposed by 
Aires et al. (2009), the aqueous extract was “moderately effective” 
against all Gram-positive isolates, and “noneffective” against all 
Gram-negative isolates. The methanolic extract was showed to be 
“noneffective” for the 23 isolates tested (Table 3). 
Since the most promising results were obtained with L. edodes var. 
Koshin mushrooms extracts, the MIC of both extracts (aqueous and 
methanolic) was only determined for this variety in Gram-positive 
clinical isolates (Table 4). In aqueous extract, the MIC values ranged 
from 15.63 to 250 µg.mL− 1, and in methanolic extract, the values ranged 
from 31.25 to 1000 µg.mL− 1. The best antimicrobial activity was ach-
ieved for MJMC 102 and MJMC 534 B clinical wound infection isolates 
and, in the MIC assay, they were the most sensitive. Noteworthy, the 
methanolic extract, that was not effective in the disc diffusion method, 
was efficient against all strains tested and the MIC values ranged from 
500 to 1000 µg.mL− 1. Regarding to MBC, the lowest concentration with 
bactericidal effect was 500 µg.mL− 1, to MJMC 111 and MJMC 552 with 
aqueous extract, and to MJMC 534 B with methanolic, all MRSA isolates. 
3.3. Synergistic effect 
Data obtained in the assessment of synergistic effect between 
L. edodes var. Koshin aqueous and methanolic extracts and commercial 
antibiotics are shown in Figure 3 and 3. Regarding to Gram-positive 
bacteria, both extracts exhibiting favourable synergistic effects with 
gentamicin (CN), vancomicyn (VA) and ciprofloxacin (CIP). No change 
in the “Resistant” to “Sensitive” profile was observed in the antibiotics 
tested, however the disk diffusion method showed an increase in halos 
size, in some cases approaching the value stipulated by the EUCAST 
(European Committee on Antimicrobial Susceptibility Testing) guide-
lines to change from” Resistant” to “Sensitive”, such as the combination 
of aqueous extract + amoxicillin / clavulanic acid (AMC) in the MJMC 
534 B ulcer clinical isolate (increased from 11 mm to 19 mm). Antag-
onistic effects were also observed with the combination of extracts and 
amoxicillin/clavulanic acid (AMC) antibiotic. 
Gram-negative bacteria (Figure 4) did not showed synergistic effects 
between extracts and the tested antibiotics. On the other hand, for 
meropenem (MEM) a decrease of ± 10 mm in halos size was observed, 
which indicated antagonism effect, and even a change in susceptibility 
profile (from “Sensitive” to “Resistant”). 
3.4. Total phenolic compounds and ortho-diphenols components 
The total phenolic compounds content in the extracts varied signif-
icantly for the two L. edodes varieties and extraction solvent used 
(Figure 5A). Comparing the methanolic and aqueous extracts from var. 
Koshin (2.07 ± 0.12 and 4.09 ± 0.59 mg GAE/g dry weight, respec-
tively), the results showed that there were significant differences con-
cerning the extraction solvent used, with the aqueous solvent presenting 
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the amount of total phenolic compounds content in aqueous var. Koshin 
extract (4.09 ± 0.59 mg GAE/g dry weight) was significantly higher 
than in the aqueous extract from var. Donko extract (2.12 ± 0.49 mg 
GAE/g dry weight), suggesting that L. edodes varieties may differ on the 
content of phenolics compounds. 
The overall trend observed for the total phenolic compounds 
(Figure 5A) content was also observed for the ortho-diphenols content 
(Figure 5B), i.e. there were significant differences between varieties of 
L. edodes and between the solvents used for extraction. As observed for 
the total phenolic compounds content, the content of ortho-diphenols in 
aqueous extracts from var. Koshin (0.11 ± 0.02 mg GAE/g dry weight) 
was significantly higher than in methanolic extract (0.04 ± 0.01 mg 
GAE/g dry weight), indicating that there were significant differences 
between the solvents used for extraction. Likewise, the content of ortho- 
diphenols in aqueous of var. Koshin extract (0.11 ± 0.02 mg GAE/g dry 
weight) was significantly higher than ortho-diphenols in aqueous var. 
Donko extract (0.08 ± 0.01mg GAE/g dry weight) in line with previ-
ously described for the total phenolic compounds content of the extracts. 
3.5. In vitro Antioxidant activity 
As shown in Figure 6, a higher ABTS•+ radical scavenging activity 
was observed for the aqueous extract of var. Koshin (1.53 ± 0.13 mmol 
Trolox / g dry weight) when compared with the methanolic extract of 
var. Koshin (0.77 ± 0.10 mmol Trolox/ g dry weight). Noteworthy, there 
was observed a significant difference between the aqueous extract of 
var. Koshin (1.53 ± 0.13 mmol Trolox / g dry weight) and aqueous 
extract of var. Donko (1.17 ± 0.10 mmol Trolox / g dry weight). 
Table 2 
Susceptibility of different antibiotics against Gram-negative bacteria.   
MJH 513 MJH 569 MJH 579 MJH 599 MJH 602 MJH 640 MJH 662 
Ampicillin nd R nd R nd R nd 
Amoxicillin/ Clavulanic acid R R R R R R R 
Piperacillin/ Tazobactam R R nd R R R R 
Imipenem I I I I I I I 
Ertapenem R R R R R R R 
Meropenem R R I S I R I 
Cefuroxim nd R nd R nd R nd 
Cefoxitin R R nd S R nd nd 
Cefotaxime R ESBL nd ESBL R R R 
Ceftazidime nd ESBL nd ESBL nd R R 
Ciprofloxacin R R nd R R S S 
Fosfomycin nd S nd S nd S nd 
Nitrofurantoin nd R nd nd nd S nd 
Norfloxacin nd R nd R nd S nd 
Levofloxacin nd R nd R nd S nd 
Gentamicin S S S S S S I 
Trimethoprim/ Sulfamethoxazole R R nd R nd S R 
Tobramycin R R nd R nd S nd 
Amikacin I I nd I I S I 
Colistin S nd nd nd S S S 
Tigecycline S nd nd nd S nd S 
S- Susceptible; I- Intermediate; R- Resistant; ESBL- Extended-spectrum beta-lactamases (this classification was made according to the interpretative breakpoints 
suggested by Clinical and Laboratory Standards Institute-CLSI); nd- not determined. 
Table 3 
In vitro antimicrobial activity of positive control and aqueous and methanolic extracts of L. edodes var. Donko and Koshin (1000 µg.mL− 1), determined by the diameter 
of inhibition zones (mm).    
AQUEOUS EXTRAC METHANOLIC EXTRAC CONTROL  
Isolate Donko Koshin Donko Koshin CN DMSO 
GRAM + MJMC 018 7 ± 0.0 (+) 10 ± 0.0 (+) 6 ± 0.0 (-) 6 ± 0,0 (-) S 24 ± 0.2 6 ± 0.0 
MJMC 025 8 ± 0.0 (+) 8 ± 0.0 (+) 6 ± 0,0 (-) 6 ± 0,0 (-) S 22 ± 0.2 
MJMC 026 8 ± 0.0 (+) 7 ± 0.0 (+) 6 ± 0.0 (-) 6 ± 0,0 (-) S 22 ± 0.0 
MJMC 027 8 ± 0.0 (+) 7 ± 0.0 (+) 6 ± 0.0 (-) 6 ± 0,0 (-) S 22 ± 0.05 
MJMC102 8 ± 0.0 (+) 12 ± 0.0 (+) 6 ± 0.0 (-) 6 ± 0,0 (-) S 25 ± 0.5 
MJMC109 9 ± 0.0 (+) 11 ± 0.0 (+) 6 ± 0.0 (-) 6 ± 0,0 (-) S 25 ± 0.5 
MJMC110 9 ± 0.0 (+) 11 ± 0.0 (+) 6 ± 0.0 (-) 6 ± 0,0 (-) S 25 ± 0.5 
MJMC111 9 ± 0.0 (+) 10 ± 0.0 (+) 6 ± 0.0 (-) 6 ± 0,0 (-) S 24 ± 1.0 
MJMC507 10 ± 0.0 (+) 10 ± 0.0 (+) 6 ± 0.0 (-) 6 ± 0,0 (-) S 25 ± 0.0 
MJMC511 10 ± 0.0 (+) 10 ± 0.0 (+) 6 ± 0.0 (-) 6 ± 0,0 (-) S 26 ± 0.5 
MJMC534 B 11 ± 0.0 (+) 16 ± 0.0 (+) 6 ± 0.0 (-) 6 ± 0,0 (-) S 27 ± 0.0 
MJMC 539 9 ± 0.0 (+) 9 ± 0.0 (+) 6 ± 0.0 (-) 6 ± 0,0 (-) R 15 ± 0.15 
MJMC 545 7 ± 0.0 (+) 8 ± 0.0 (+) 6 ± 0.0 (-) 6 ± 0,0 (-) S 23 ± 0.25 
MJMC 552 9 ± 0.0 (+) 9 ± 0.0 (+) 6 ± 0.0 (-) 6 ± 0,0 (-) S 25 ± 0.2 
CETC976 7 ± 0.0 (+) 7 ± 0.0 (+) 6 ± 0.0 (-) 6 ± 0,0 (-) S 22 ± 0.0 
GRAM - MJH513 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) S 17 ± 0.0 6 ± 0.0 
MJH569 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) S 21 ± 0.0 
MJH579 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) S 19 ± 0.5 
MJH599 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) S 18 ± 0.0 
MJH602 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) R 22 ± 0.5 
MJH640 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) S 20 ± 0.0 
MJH662 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) R 13 ± 0.0 
CETC434 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) 6 ± 0.0 (-) S 20 ± 0.0 
Results are expressed as mean ± SD (standard deviation) of 2 replicates. Note: 6 mm value corresponds to disc diameter. 
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Moreover, the ABTS•+ radical scavenging activity of the aqueous 
extract of var. Donko (1.17 ± 0.10 mmol Trolox / g dry weight) was 
significantly higher than the methanolic extract of var. Koshin (0.77 ±
0.10 mmol Trolox/ g dry weight) (Figure 6). These results are in 
accordance with the results obtained for the total phenolic compounds 
and ortho-diphenols contents of both methanolic and aqueous extracts. 
On the other hand, no differences in the ABTS+. scavenging activity 
were observed between the methanolic extracts of var. Koshin and 
Donko. 
4. Discussion 
The rapid emergence of resistant bacteria is universal compromising 
the efficacy of the existing available antibiotics. Currently, the most 
notorious multidrug-resistant bacteria have been identified as the so- 
called “ESKAPE” which includes S. aureus, and K. pneumoniae being 
responsible for significant high morbidity and mortality (Li and 
Webster, 2018). 
According to the OECD’s projections, by 2050 Italy, Greece and 
Portugal “will have the highest mortality due to antimicrobial resis-
tance” among EU members (OECD, 2018). Hence, there is an urgent 
need for the development of new and effective drugs against current 
multidrug-resistant pathogens (Zaman et al., 2017). Natural resources 
have been widely exploited, being fungal species an important potential 
source of bioactive compounds with exceptional therapeutic value 
(Poucheret et al., 2006). Herein, the two varieties of Lentinula edodes 
were assessed as an alternative to fight antibiotics resistance. Accord-
ingly, the present study aimed to evaluate the antimicrobial properties 
of L. edodes var. Koshin and Donko aqueous and methanolic extracts and 
its synergistic effect with current clinical antimicrobials in multidrug 
resistant bacteria isolates obtained from a Portuguese hospital. Note-
worthy, for the first time, the two varieties of L. edodes were compared 
concerning to phytochemical composition and antimicrobial activity. 
The evaluation of antimicrobial activity, by disc diffusion method, 
revealed that both aqueous extracts were effective against Gram- 
positive bacteria (MSSA and MRSA), and both methanolic extracts 
were not effective against either isolates. Aqueous extracts from the 
L. edodes var. Koshin showed the best results, since the highest antimi-
crobial activity was obtained against to MRSA MJMC 534B. This is a 
result of great importance since the incidence of MRSA, especially in 
Portuguese hospitals, is one of the most important in Europe (45%) 
(ECDC, 2017). Noteworthy, it should be pointed out that MRSA MJMC 
534B is clinical wound infection isolate causing high morbidity and 
mortality; longer hospital stays, delay in wound healing, increase eco-
nomic burden and discomfort. Therefore, these results obtained with 
aqueous extracts on Gram-positive isolates are an important step to-
wards to search for new effective agents against S. aureus in infected 
wounds. These results are in accordance with previous reports, in which 
different extracts from 48 mushroom species including L. edodes, were 
evaluated and it was observed that Gram-positive bacteria were more 
sensitive than Gram-negative bacteria. Among all extracts, the aqueous 
extracts of Clitocybe geotropa and Lentinula edodes showed the highest 
antimicrobial activity against all strains tested (Venturini et al., 2008). In 
agreement, in another study, the aqueous L. edodes demonstrated 
notable antimicrobial activity against MRSA (Hearst et al., 2009). The 
antimicrobial differences between the two L. edodes varieties and two 
solvents (aqueous and methanol) may be due to the total phenols and 
ortho-diphenols contents present, which was higher for the aqueous 
extract of the Koshin variety. In fact, several authors have previously 
associated the antimicrobial activity of different natural sources to 
phenolic compounds (Barros et al., 2008; Alves et al., 2012). Usually, the 
differences observed between varieties can be explained by several 
factors, namely, genetic, physiological and morphologic characteristics, 
agroclimatic conditions and ripening stage and in this case, the differ-
ences in phenols content, as well as antioxidant activity are probably, 
Figure 2. In vitro antimicrobial activity of positive control (Gentamicin) and aqueous extracts of L. edodes var. Donko and Koshin (1000 µg.mL− 1) against Gram- 
positive isolates, determined by the diameter of inhibition zones (mm). 
Table 4 
Minimum Inhibitory Concentration (µg.mL− 1) and Minimum Bactericidal Con-






Isolate CMI CMB CMI CMB CMI 
MRSA MJMC 025 250 >1000 1000 >1000 125 
MJMC 027 125 >1000 500 >1000 125 
MJMC102 62.5 >1000 250 1000 7.81 
MJMC111 62.5 500 500 >1000 7.81 
MJMC507 125 >1000 250 1000 7.81 
MJMC534 B 62.5 1000 500 500 7.81 
MJMC 539 125 >1000 500 >1000 62.5 
MJMC 545 125 >1000 500 >1000 125 
MJMC 552 250 500 500 1000 125 
MSSA MJMC 018 62.5 >1000 500 >1000 7.81 
MJMC 026 125 >1000 1000 1000 125 
MJMC109 125 1000 1000 >1000 125 
MJMC110 62.5 1000 500 1000 62.5 
MJMC511 62.5 1000 500 1000 7.81 
CETC976 15.63 n.d. 31.25 n.d. 7.81  
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mainly due to genetic, morphologic characteristics and growing 
conditions. 
It should be highlighted that more studies should be performed in 
order to elucidate the mechanism of bacteriostatic or bactericide effect 
and the specific phenolic/ ortho-diphenols compounds found in these 
extracts should be tested against selected bacteria in order to identify 
molecules responsible for the mushrooms bioactivity. 
In the MIC determination, methanolic extracts also had antimicrobial 
activity, however with higher MIC values. These results do not match 
those obtained in disc diffusion method. However, the absence of an 
inhibition zone does not necessarily mean that the extract is not effective 
against that microorganisms, although rather that the diffusion was not 
complete, especially for the less polar compounds that diffuse more 
slowly into the culture medium (Moreno et al., 2006). 
Regarding the evaluation of synergistic effect, this is a pioneer study 
between L. edodes different extracts and commercial antibiotics and 
constitutes an important step, since the current available data are 
mainly correlated with plant extracts and not with mushroom extracts 
Figure 3. Inhibition zone diameter (mm) in the synergistic effect assessment with combination of L. edodes var Koshin aqueous/methanolic extracts and (A) 
Gentamicin, (B) Amoxicilin /clavulanic acid, (C) Ciprofloxacin, (D) Vancomycin on Gram-negative isolates. 
Guidelines EUCAST/CLSI for Staphylococcus aureus: CN S ≥18 mm; AMC) ≥20; CIP S ≥21 mm; VA S ≥12 mm. 
Figure 4. Inhibition zone diameter (mm) in the synergistic effect assessment with combination of L. edodes var Koshin aqueous/methanolic extracts and (A) 
Gentamicin, (B) Ertapenem, (C) Imipenem, (D) Meropenem on Gram-negative isolates. 
Guidelines EUCAST/CLSI for Klebsiella pneumoniae: CN S ≥14 mm; ETP S ≥25 mm; IPM S ≥17 mm; AMC S ≥19 mm; MEM S ≥16 mm. 
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(Alves et al., 2014). The synergistic effect between mushrooms extracts 
and antibiotic may constitute a strategy employed for protection against 
increasing microorganism’s resistance. The results obtained showed that 
there was a synergistic effect between both mushrooms extracts and 
some standard antibiotics for Gram-positives bacteria namely genta-
micin, vancomicyn, and ciprofloxacin. No change in the “Resistant” to 
“Sensitive” profile were observed, however, in some cases, the halo 
value size approached the value determined by EUCAST to change from 
“Resistant” to “Sensitive”. Similar to this result, Alves et al. (2014) re-
ported synergistic effect against MRSA using methanol and aqueous 
extracts from different wild mushroom species, and synergistic effects 
were observed for two quinolones (ciprofloxacin and levofloxacin) and 
for some β-lactams (penicillin, ampicillin and cefoxitin). Other authors 
have also reported synergistic effects of plant extracts and quinolones 
(ciprofloxacin and levofloxacin) against MRSA (An et al., 2011). 
Antagonistic effects were also observed with extracts + amoxicillin/ 
clavulanic acid combination, which may be explained by the amount of 
metabolites present in the extracts that may lead to decrease of the 
active substances action, through competitiveness by the same action 
target and / or through inhibition of antibiotic active principle. Gram- 
negative isolates showed antagonism with the addition of extracts to 
meropenem. The carbapenem group represents a last line in the fight 
against multidrug resistant bacterial infections, due to the broad spec-
trum of action against Gram-negative and Gram-positive bacteria, 
including ESBL-producing microorganisms. Carbapenems act by inhib-
iting bacterial cell wall synthesis by binding and inactivating PBPs 
(Penicillin-binding proteins). The intensity of binding to PBPs depends 
the type of carbapenem. Meropenem has a high affinity for PBP 3 rela-
tive to imipenem and ertapenem (Meroueh et al., 2006). Here, the 
possibility that some compounds, present in the mushroom extract, will 
first bind to PBP 3 may justify this antagonistic effect. 
These extracts, as well as specific compounds, should be evaluated 
for further conclusions. Moreover, more studies are required in order to 
clarify the mechanisms of action that support the observed effects upon 
each antibiotic and microorganism. 
Given the problem associated with antibiotic resistance worldwide, 
Lentinula edodes is a potential source of antibacterial compounds that 
can be used prophylactically to prevent the risk of infection and may be 
used in combination with antibiotics, to reduce the time of infection and 
the possible occurrence of resistance phenomena. 
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